This inventor holds 1 USPTO granted patent. Top assignee: Fotona D.o.o.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Julio Cezar Velez Ocampo: Innovator in Laser Treatment for Hyperpigmentation
Introduction
Julio Cezar Velez Ocampo is a notable inventor based in Bogota, Colombia. He has made significant contributions to the field of dermatology through his innovative approach to treating melasma and related hyperpigmentation disorders. His work exemplifies the intersection of technology and healthcare, aiming to improve patient outcomes.
Latest Patents
Julio holds a patent for a method and apparatus for treating melasma and/or related hyperpigmentation disorders. This patent, which is one of his key achievements, involves delivering laser pulses onto a patient's body. The treatment includes several steps, such as delivering laser pulses with a diameter of at least 100 μm and a duration of at most 1 μs, as well as configurations that include a plurality of microbeams, each having a diameter below 1 mm. This innovative approach has the potential to revolutionize the way hyperpigmentation is treated.
Career Highlights
Julio is currently associated with Fotona D.o.o., a company known for its advanced laser technologies. His work at Fotona has allowed him to explore and develop cutting-edge solutions in the field of dermatology. His dedication to innovation is evident in his research and the practical applications of his inventions.
Collaborations
Julio collaborates with talented professionals in his field, including Marcelo Tettamanti and Sebastian Velez Ocampo. These collaborations enhance the quality and impact of his work, fostering an environment of shared knowledge and innovation.
Conclusion
Julio Cezar Velez Ocampo is a pioneering inventor whose work in laser treatment for hyperpigmentation disorders showcases his commitment to advancing medical technology. His contributions are significant in improving treatment options for patients suffering from these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile